Fig 1: Correlation between Neuronal pentraxin 2 levels and Mini-mental state examination score, age and epilepsy duration. A to C: Correlation between serum levels of NPTX2 and MMSE score in (A), age (B), and epilepsy duration (C) in epilepsy patients with cognitive dysfunction. NPTX2: Neuronal pentraxin 2; MMSE: Mini-mental state examination.
Fig 2: Serum levels of neuronal pentraxin 2 among study participants. Control: Healthy volunteers (n = 30); Normal: Epilepsy patients with normal cognitive function (n = 74); epilepsy patients with cognitive dysfunction (n = 37). ECD: Epilepsy patients with cognitive dysfunction; NPTX2: Neuronal pentraxin 2.
Fig 3: Relationship between NPTX2 levels and ECG values in different regions. Correlation between NPTX2 serum levels and EEG values in the frontal (A), central (B), and temporal (C) regions of patients with epilepsy and cognitive dysfunction. ECG: Electrocardiogram; NPTX2: Neuronal pentraxin 2.
Fig 4: Comparison between neuronal pentraxin 2 serum levels and different variables in patients with epilepsy and cognitive dysfunction. A to E: Gender(A), education level (B), epilepsy type (C), epilepsy drug types (D), and treatment protocol (E). ECD: Epilepsy patients with cognitive dysfunction; NPTX2: Neuronal pentraxin 2; VPA: Valproate.
Fig 5: Receiver operating characteristic curve for predicting serum level values and electroencephalogram values in temporal region in patients with epilepsy and cognitive dysfunction. ECG: Electrocardiogram; NPTX2: Neuronal pentraxin 2.
Supplier Page from CUSABIO Technology LLC for Human Neuronal pentraxin-2(NPTX2) ELISA Kit